Terry Smith
Fundsmith
Fundsmith Portfolio 13F
Terry Smith Holdings Activity
- Portfolio value:
- $23.02B≈ (+$1B≈)
- Previous value:
- $21.97B≈
- # of changes:
- 34
- New positions:
- 3
- Reported for:
- 30 Jun 2025 (Q2)
- Latest filing date:
- 14 Aug 2025
Fundsmith has disclosed a total of 34 changes to the portfolio in the (2025 Q2) SEC report(s): increased the number of shares of 4, bought 3 totally new, decreased the number of shares of 25 and completely sold out 2 position(s).
What stocks did Terry Smith buy in 2025 Q2?
During 2025 Q2 Terry Smith has bought 7 securities out of which top 5 purchases (by % change to portfolio) were (ZTS) Zoetis Inc (added shares +13.29%), (INTU) Intuit Inc (added shares +102.91%), (VRT) Vertiv Holdings Co (new buy), (DOCS) Doximity Inc (added shares +13.96%) and (CPRX) Catalyst Pharmaceuticals Inc (added shares +25.93%).
In the 2025 Q2 report(s) the following changes have been made to the top investments: (META) Meta Platforms Inc (reduced shares -8.11%), (MSFT) Microsoft Corp (reduced shares -7.98%), (SYK) Stryker Corp (reduced shares -7.74%), (PM) Philip Morris International Inc (reduced shares -16.03%) and (IDXX) IDEXX Laboratories Inc (reduced shares -0.34%).
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.